|
[´ã´ç¾÷¹«] • ÇØ¿Ü Á¦¾à»ç, ¹ÙÀÌ¿ÀÅØ, CMO, ÀÇ·á±â±â ¾÷ü ´ë»ó ¶óÀ̼±½º ÀÎ/¾Æ¿ô, °øµ¿°³¹ß, ±â¼úÀÌÀü, »ó¿ëÈ ÆÄÆ®³Ê½Ê ¹ß±¼ ¹× Çù»ó • ¹Ì±¹, À¯·´, ¾Æ½Ã¾Æ, MENA µî ÁÖ¿ä Áö¿ªÀÇ ÀáÀç ÆÄÆ®³Ê ¹ß±¼ ¹× °ü°è ±¸Ãà, ±âÁ¸ ÆÄÆ®³Ê½Ê °ü¸®(KPI, ¼º°ú ¸ð´ÏÅ͸µ) • ±Û·Î¹ú ½ÃÀ塤°æÀï»ç¡¤ÆÄÀÌÇÁ¶óÀΡ¤±ÔÁ¦ ȯ°æ ºÐ¼®À» ÅëÇÑ ºñÁî´Ï½º ±âȸ ¹ß±¼ ¹× »ç¾÷ Ÿ´ç¼º °ËÅä(Feasibility, Valuation Áö¿ø) • CDA, LOI, Term Sheet, Licensing Agreement µî °è¾à ¹®¼ ÃÊ¾È ÀÛ¼º ¹× Á¶°Ç Çù»ó, ¹ý¹«¡¤RA¡¤À繫¡¤CMC¡¤¸¶ÄÉÆÃ µî°úÀÇ Cross-functional Çù¾÷ • CPhI, BIO International µî ±¹Á¦ Àü½Ã¡¤ÄÁÆÛ·±½º ¹× ÆÄÆ®³Ê ¹ÌÆÃ ±âȹ¡¤Âü¼®, ±â¾÷/Á¦Ç° ¼Ò°³ÀÚ·á ¹× ÇÁ·¹Á¨Å×ÀÌ¼Ç ¼öÇà • BD Pipeline ¹× Deal ÁøÇà ÇöȲ °ü¸®
[±Ù¹«ºÎ¼ ¹× Á÷±Þ/Á÷Ã¥] Á÷±Þ/Á÷Ã¥: ´ë¸®, °úÀå, Â÷Àå
|
[ÀÚ°Ý¿ä°Ç] °æ·Â: °æ·Â 5~12³â ÇзÂ: ´ëÁ¹ ÀÌ»ó Á÷¹«±â¼ú: BD, ÇØ¿Ü»ç¾÷ BD
|